Frontlight ResearchEarly access
CompletedNo phase
The Effect of NP-2006 on Sleep Quality and Health
Key facts
- Who runs it
- Hanpoong Nature Pharm Co., Ltd.
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 48 people enrolled
- Started
- 12 May 2023
- Ended
- 13 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- NP-2006
- Placebo
- Record updated
- 27 March 2026
Who can take part
- Age
- 19 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Those who agreed to participate in this study and signed a written consent form
- Adults aged 19 to 65 years, male or female
- Those with poor sleep quality (PSQI score > 5 points)
Who cannot take part
- Those taking medications (corticosteroids, psychotropic medications, etc.) that could affect sleep within 1 month of the first visit or expected to take them during the study participation
- Those receiving hormone therapy
- Those with the following conditions:; Snoring, sleep apnea, restless legs syndrome, periodic limb movement disorder (PLMD), depression, narcolepsy, or respiratory disease that cause sleep disturbances; Itching, nocturia, chronic pain, or muscle cramps that affect sleep; Uncontrolled diabetes or hypertension
- Those who are hypersensitive to ingredients in the test or control foods or have experienced severe food allergies
- Those with severe sleep disturbances (ISI ≥ 22 points)
- Those with severe daytime sleepiness (ESS ≥ 16 points)
- Those experiencing changes that could cause excessive stress within 2 weeks of the first visit: death of a spouse, family discord, lawsuits/disputes, sudden financial difficulties, immigration, etc
- Those who regularly consume excessive alcohol; Men > 210 g/week (approximately 4 bottles of soju/week, approximately 4 glasses/day); Women > 140 g/week (approximately 2.5 bottles of soju/week, approximately 2.5 glasses/day)
- Those who smoke excessively (> 10 cigarettes/day) or show withdrawal symptoms
- Those who consume excessive amounts of caffeine (> 3 cups/day)
- Those who work night shifts or have irregular bedtimes due to their job
- Those who have traveled or plan to travel long distances to a country with a different time zone within 1 month of the first visit
- Those with a BMI of 18 kg/m2 or less or 35 kg/m2 or more
- Those who have continuously taken herbal medicines or health functional foods that may affect sleep within 1 month of the first visit
- Those who have participated in a clinical trial within 1 month of the first visit
- Those who are pregnant or lactating, or who are planning to become pregnant
- Those who the researcher deems unsuitable for participation in this study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main objective will be to assess the effect of NP-2006 on sleep efficiency in volunteers presented with persistent subclinical insomnia
The 2 groups in the trial
- Sequence A (NP-2006 first, then Placebo)Treatment being tested
Group that took tablets containing 500mg of NP-2006 (NP-2006, crystalline cellulose, tapioca starch, hydroxypropylmethylcellulose, etc.) 30 to 60 minutes before going to sleep
Treatment: NP-2006 and Placebo
- Sequence B (Placebo first, then NP-2006)Placebo, for comparison
Group that took tablets not containing NP-2006 (crystalline cellulose, maltodextrin, lactose mixed powder, hydroxypropylmethylcellulose, etc.) 30 to 60 minutes before bedtime
Treatment: NP-2006 and Placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of NP-2006 on Sleep Efficiency and Quality in Healthy Volunteers With Persistent Subclinical Insomnia
- Record updated
- 27 March 2026